{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:14:24Z","timestamp":1795130064407,"version":"4.10.3"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41581-025-01028-y","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:09:49Z","timestamp":1763741389000},"page":"229-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The glomerular endothelial glycocalyx as a therapeutic target in proteinuric kidney disease"],"prefix":"10.1038","volume":"22","author":[{"given":"Monica","family":"Gamez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-5081","authenticated-orcid":false,"given":"Raina D.","family":"Ramnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9814-8008","authenticated-orcid":false,"given":"Matthew J.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5276-4537","authenticated-orcid":false,"given":"Simon C.","family":"Satchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"1028_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 395, 709\u2013733 (2020).","journal-title":"Lancet"},{"key":"1028_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy, C. P. Epidemiology of chronic kidney disease: an update 2022. Kidney Int. Suppl. 12, 7\u201311 (2022).","journal-title":"Kidney Int. Suppl."},{"key":"1028_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/bcp.12104","volume":"76","author":"P Cravedi","year":"2013","unstructured":"Cravedi, P. & Remuzzi, G. Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br. J. Clin. Pharmacol. 76, 516\u2013523 (2013).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"1028_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1152\/physrev.00055.2006","volume":"88","author":"B Haraldsson","year":"2008","unstructured":"Haraldsson, B., Nystrom, J. & Deen, W. M. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 88, 451\u2013487 (2008).","journal-title":"Physiol. Rev."},{"key":"1028_CR5","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00125-008-0961-8","volume":"51","author":"SC Satchell","year":"2008","unstructured":"Satchell, S. C. & Tooke, J. E. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 51, 714\u2013725 (2008).","journal-title":"Diabetologia"},{"key":"1028_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-96445-4_1","volume":"1097","author":"Y Zeng","year":"2018","unstructured":"Zeng, Y., Zhang, X. F., Fu, B. M. & Tarbell, J. M. The role of endothelial surface glycocalyx in mechanosensing and transduction. Adv. Exp. Med. Biol. 1097, 1\u201327 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1028_CR7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1161\/ATVBAHA.118.310839","volume":"38","author":"S Dogne","year":"2018","unstructured":"Dogne, S., Flamion, B. & Caron, N. Endothelial glycocalyx as a shield against diabetic vascular complications: involvement of hyaluronan and hyaluronidases. Arterioscler. Thromb. Vasc. Biol. 38, 1427\u20131439 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1028_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","volume":"454","author":"S Reitsma","year":"2007","unstructured":"Reitsma, S., Slaaf, D. W., Vink, H., van Zandvoort, M. A. & oude Egbrink, M. G. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 454, 345\u2013359 (2007).","journal-title":"Pflugers Arch."},{"key":"1028_CR9","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.bpj.2011.07.036","volume":"101","author":"KP Arkill","year":"2011","unstructured":"Arkill, K. P. et al. Similar endothelial glycocalyx structures in microvessels from a range of mammalian tissues: evidence for a common filtering mechanism? Biophys. J. 101, 1046\u20131056 (2011).","journal-title":"Biophys. J."},{"key":"1028_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.766689","volume":"8","author":"BJ Ballermann","year":"2021","unstructured":"Ballermann, B. J., Nystr\u00f6m, J. & Haraldsson, B. The glomerular endothelium restricts albumin filtration. Front. Med. 8, 766689 (2021).","journal-title":"Front. Med."},{"key":"1028_CR11","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1111\/febs.17107","volume":"291","author":"S Ricard-Blum","year":"2024","unstructured":"Ricard-Blum, S. et al. A biological guide to glycosaminoglycans: current perspectives and pending questions. FEBS J. 291, 3331\u20133366 (2024).","journal-title":"FEBS J."},{"key":"1028_CR12","doi-asserted-by":"publisher","first-page":"21032","DOI":"10.1074\/jbc.M702073200","volume":"282","author":"S Kurup","year":"2007","unstructured":"Kurup, S. et al. Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4. J. Biol. Chem. 282, 21032\u201321042 (2007).","journal-title":"J. Biol. Chem."},{"key":"1028_CR13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/ki.2014.115","volume":"86","author":"AL Rops","year":"2014","unstructured":"Rops, A. L. et al. Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis. Kidney Int. 86, 932\u2013942 (2014).","journal-title":"Kidney Int."},{"key":"1028_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41586-025-08589-9","volume":"639","author":"SM Shi","year":"2025","unstructured":"Shi, S. M. et al. Glycocalyx dysregulation impairs blood-brain barrier in ageing and disease. Nature 639, 985\u2013994 (2025).","journal-title":"Nature"},{"key":"1028_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/jsbi.2002.4441","volume":"136","author":"JM Squire","year":"2001","unstructured":"Squire, J. M. et al. Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? J. Struct. Biol. 136, 239\u2013255 (2001).","journal-title":"J. Struct. Biol."},{"key":"1028_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1549-8719.2012.00168.x","volume":"19","author":"KP Arkill","year":"2012","unstructured":"Arkill, K. P. et al. 3D reconstruction of the glycocalyx structure in mammalian capillaries using electron tomography. Microcirculation 19, 343\u2013351 (2012).","journal-title":"Microcirculation"},{"key":"1028_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.734661","volume":"9","author":"KP Arkill","year":"2021","unstructured":"Arkill, K. P. A reinterpretation of evidence for the endothelial glycocalyx filtration structure. Front. Cell Dev. Biol. 9, 734661 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1028_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbplus.2022.100121","volume":"16","author":"D Pretorius","year":"2022","unstructured":"Pretorius, D., Richter, R. P., Anand, T., Cardenas, J. C. & Richter, J. R. Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function. Matrix Biol. 16, 100121 (2022).","journal-title":"Matrix Biol."},{"key":"1028_CR19","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.kint.2017.12.003","volume":"93","author":"S Desideri","year":"2018","unstructured":"Desideri, S. et al. A novel assay provides sensitive measurement of physiologically relevant changes in albumin permeability in isolated human and rodent glomeruli. Kidney Int. 93, 1086\u20131097 (2018).","journal-title":"Kidney Int."},{"key":"1028_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086249","volume":"9","author":"Y Zeng","year":"2014","unstructured":"Zeng, Y. & Tarbell, J. M. The adaptive remodeling of endothelial glycocalyx in response to fluid shear stress. PLoS ONE 9, e86249 (2014).","journal-title":"PLoS ONE"},{"key":"1028_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/cvr\/cvq146","volume":"87","author":"JM Tarbell","year":"2010","unstructured":"Tarbell, J. M. Shear stress and the endothelial transport barrier. Cardiovasc. Res. 87, 320\u2013330 (2010).","journal-title":"Cardiovasc. Res."},{"key":"1028_CR22","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.2147\/IJN.S437714","volume":"19","author":"SG Twamley","year":"2024","unstructured":"Twamley, S. G. et al. Lack of laminar shear stress facilitates the endothelial uptake of very small superparamagnetic iron oxide nanoparticles by modulating the endothelial surface layer. Int. J. Nanomed. 19, 3123\u20133142 (2024).","journal-title":"Int. J. Nanomed."},{"key":"1028_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/bcp.12629","volume":"80","author":"BF Becker","year":"2015","unstructured":"Becker, B. F., Jacob, M., Leipert, S., Salmon, A. H. & Chappell, D. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br. J. Clin. Pharmacol. 80, 389\u2013402 (2015).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"1028_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.apha.2017.08.002","volume":"81","author":"X Wang","year":"2018","unstructured":"Wang, X. & Khalil, R. A. Matrix metalloproteinases, vascular remodeling, and vascular disease. Adv. Pharmacol. 81, 241\u2013330 (2018).","journal-title":"Adv. Pharmacol."},{"key":"1028_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.kint.2018.08.024","volume":"95","author":"MJ Butler","year":"2019","unstructured":"Butler, M. J. et al. Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx. Kidney Int. 95, 94\u2013107 (2019).","journal-title":"Kidney Int."},{"key":"1028_CR26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.kint.2019.09.035","volume":"97","author":"RD Ramnath","year":"2020","unstructured":"Ramnath, R. D. et al. Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease. Kidney Int. 97, 951\u2013965 (2020).","journal-title":"Kidney Int."},{"key":"1028_CR27","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1096\/fj.14-252221","volume":"28","author":"R Ramnath","year":"2014","unstructured":"Ramnath, R. et al. Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor \u03b1: a contributor to endothelial cell glycocalyx dysfunction. FASEB J. 28, 4686\u20134699 (2014).","journal-title":"FASEB J."},{"key":"1028_CR28","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/glycob\/cwj098","volume":"16","author":"S Brule","year":"2006","unstructured":"Brule, S. et al. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1\/CXCL12 and mediated by the matrix metalloproteinase-9. Glycobiology 16, 488\u2013501 (2006).","journal-title":"Glycobiology"},{"key":"1028_CR29","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1083\/jcb.148.4.811","volume":"148","author":"ML Fitzgerald","year":"2000","unstructured":"Fitzgerald, M. L., Wang, Z., Park, P. W., Murphy, G. & Bernfield, M. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J. Cell Biol. 148, 811\u2013824 (2000).","journal-title":"J. Cell Biol."},{"key":"1028_CR30","doi-asserted-by":"publisher","first-page":"34836","DOI":"10.1074\/jbc.M112.390161","volume":"287","author":"S Peterson","year":"2012","unstructured":"Peterson, S. & Liu, J. Deciphering mode of action of heparanase using structurally defined oligosaccharides. J. Biol. Chem. 287, 34836\u201334843 (2012).","journal-title":"J. Biol. Chem."},{"key":"1028_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells7120236","volume":"7","author":"V Masola","year":"2018","unstructured":"Masola, V., Bellin, G., Gambaro, G. & Onisto, M. Heparanase: a multitasking protein involved in extracellular matrix (ECM) remodeling and intracellular events. Cells 7, 236 (2018).","journal-title":"Cells"},{"key":"1028_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/s-0041-1725066","volume":"47","author":"I Vlodavsky","year":"2021","unstructured":"Vlodavsky, I., Barash, U., Nguyen, H. M., Yang, S. M. & Ilan, N. Biology of the heparanase-heparan sulfate axis and its role in disease pathogenesis. Semin. Thromb. Hemost. 47, 240\u2013253 (2021).","journal-title":"Semin. Thromb. Hemost."},{"key":"1028_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202212636","volume":"62","author":"D Mah","year":"2023","unstructured":"Mah, D. et al. Apolipoprotein E recognizes Alzheimer\u2019s disease associated 3-O sulfation of heparan sulfate. Angew. Chem. Int. Ed. 62, e202212636 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1028_CR34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/1933719112453508","volume":"20","author":"KF Hofmann-Kiefer","year":"2013","unstructured":"Hofmann-Kiefer, K. F. et al. Increased serum concentrations of circulating glycocalyx components in HELLP syndrome compared to healthy pregnancy: an observational study. Reprod. Sci. 20, 318\u2013325 (2013).","journal-title":"Reprod. Sci."},{"key":"1028_CR35","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1681\/ASN.2011121181","volume":"23","author":"CA Vlahu","year":"2012","unstructured":"Vlahu, C. A. et al. Damage of the endothelial glycocalyx in dialysis patients. J. Am. Soc. Nephrol. 23, 1900\u20131908 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1028_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.clinbiochem.2016.02.014","volume":"49","author":"D Anand","year":"2016","unstructured":"Anand, D., Ray, S., Srivastava, L. M. & Bhargava, S. Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients. Clin. Biochem. 49, 768\u2013776 (2016).","journal-title":"Clin. Biochem."},{"key":"1028_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/SHK.0b013e3181777da3","volume":"30","author":"A Nelson","year":"2008","unstructured":"Nelson, A., Berkestedt, I., Schmidtchen, A., Ljunggren, L. & Bodelsson, M. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 30, 623\u2013627 (2008).","journal-title":"Shock"},{"key":"1028_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.154164","volume":"8","author":"M Crompton","year":"2023","unstructured":"Crompton, M. et al. Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyx. JCI Insight 8, e154164 (2023).","journal-title":"JCI Insight"},{"key":"1028_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/32.3.6198357","volume":"32","author":"AL Baldwin","year":"1984","unstructured":"Baldwin, A. L. & Winlove, C. P. Effects of perfusate composition on binding of ruthenium red and gold colloid to glycocalyx of rabbit aortic endothelium. J. Histochem. Cytochem. 32, 259\u2013266 (1984).","journal-title":"J. Histochem. Cytochem."},{"key":"1028_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db18-0045","volume":"68","author":"KL Onions","year":"2019","unstructured":"Onions, K. L. et al. VEGFC reduces glomerular albumin permeability and protects against alterations in VEGF receptor expression in diabetic nephropathy. Diabetes 68, 172\u2013187 (2019).","journal-title":"Diabetes"},{"key":"1028_CR41","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00125-022-05650-4","volume":"65","author":"Y Qiu","year":"2022","unstructured":"Qiu, Y. et al. Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice. Diabetologia 65, 879\u2013894 (2022).","journal-title":"Diabetologia"},{"key":"1028_CR42","first-page":"77","volume":"56","author":"J Fan","year":"2019","unstructured":"Fan, J., Sun, Y., Xia, Y., Tarbell, J. M. & Fu, B. M. Endothelial surface glycocalyx (ESG) components and ultra-structure revealed by stochastic optical reconstruction microscopy (STORM). Biorheology 56, 77\u201388 (2019).","journal-title":"Biorheology"},{"key":"1028_CR43","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1113\/JP274167","volume":"595","author":"KB Betteridge","year":"2017","unstructured":"Betteridge, K. B. et al. Sialic acids regulate microvessel permeability, revealed by novel in vivo studies of endothelial glycocalyx structure and function. J. Physiol. 595, 5015\u20135035 (2017).","journal-title":"J. Physiol."},{"key":"1028_CR44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00795-023-00360-1","volume":"56","author":"M Wakatsuki","year":"2023","unstructured":"Wakatsuki, M., Takaki, T., Ushiyama, A., Honda, K. & Iijima, T. Fast-track preparation of lung specimens for electron microscope observations of the pulmonary endothelial glycocalyx. Med. Mol. Morphol. 56, 239\u2013249 (2023).","journal-title":"Med. Mol. Morphol."},{"key":"1028_CR45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2215\/CJN.08160813","volume":"9","author":"MJ Dane","year":"2014","unstructured":"Dane, M. J. et al. Association of kidney function with changes in the endothelial surface layer. Clin. J. Am. Soc. Nephrol. 9, 698\u2013704 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1028_CR46","doi-asserted-by":"publisher","first-page":"22102","DOI":"10.1073\/pnas.0902639106","volume":"106","author":"RM Bellin","year":"2009","unstructured":"Bellin, R. M. et al. Defining the role of syndecan-4 in mechanotransduction using surface-modification approaches. Proc. Natl Acad. Sci. USA 106, 22102\u201322107 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1028_CR47","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/01.ATV.0000085630.24353.3D","volume":"23","author":"AA Constantinescu","year":"2003","unstructured":"Constantinescu, A. A., Vink, H. & Spaan, J. A. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler. Thromb. Vasc. Biol. 23, 1541\u20131547 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1028_CR48","doi-asserted-by":"publisher","first-page":"R508","DOI":"10.1152\/ajpregu.00340.2020","volume":"320","author":"KH Moore","year":"2021","unstructured":"Moore, K. H., Murphy, H. A. & George, E. M. The glycocalyx: a central regulator of vascular function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 320, R508\u2013R518 (2021).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"1028_CR49","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/cvr\/cvq062","volume":"87","author":"JR Levick","year":"2010","unstructured":"Levick, J. R. & Michel, C. C. Microvascular fluid exchange and the revised Starling principle. Cardiovasc. Res. 87, 198\u2013210 (2010).","journal-title":"Cardiovasc. Res."},{"key":"1028_CR50","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1113\/jphysiol.1896.sp000596","volume":"19","author":"EH Starling","year":"1896","unstructured":"Starling, E. H. On the absorption of fluids from the connective tissue spaces. J. Physiol. 19, 312\u2013326 (1896).","journal-title":"J. Physiol."},{"key":"1028_CR51","doi-asserted-by":"publisher","first-page":"623671","DOI":"10.3389\/fvets.2021.623671","volume":"8","author":"TE Woodcock","year":"2021","unstructured":"Woodcock, T. E. & Michel, C. C. Advances in the Starling principle and microvascular fluid exchange; consequences and implications for fluid therapy. Front. Vet. Sci. 8, 623671 (2021).","journal-title":"Front. Vet. Sci."},{"key":"1028_CR52","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1113\/jphysiol.2003.058255","volume":"557","author":"RH Adamson","year":"2004","unstructured":"Adamson, R. H. et al. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J. Physiol. 557, 889\u2013907 (2004).","journal-title":"J. Physiol."},{"key":"1028_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.exer.2018.11.012","volume":"179","author":"W Leskova","year":"2019","unstructured":"Leskova, W. et al. Effect of diabetes and hyaluronidase on the retinal endothelial glycocalyx in mice. Exp. Eye Res. 179, 125\u2013131 (2019).","journal-title":"Exp. Eye Res."},{"key":"1028_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02133-1","volume":"23","author":"M Gamez","year":"2024","unstructured":"Gamez, M. et al. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes. Cardiovasc. Diabetol. 23, 50 (2024).","journal-title":"Cardiovasc. Diabetol."},{"key":"1028_CR55","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/00000542-200405000-00025","volume":"100","author":"M Rehm","year":"2004","unstructured":"Rehm, M. et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 100, 1211\u20131223 (2004).","journal-title":"Anesthesiology"},{"key":"1028_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbplus.2021.100094","volume":"12","author":"RC Sullivan","year":"2021","unstructured":"Sullivan, R. C., Rockstrom, M. D., Schmidt, E. P. & Hippensteel, J. A. Endothelial glycocalyx degradation during sepsis: causes and consequences. Matrix Biol. 12, 100094 (2021).","journal-title":"Matrix Biol."},{"key":"1028_CR57","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrm.2016.80","volume":"17","author":"C Zihni","year":"2016","unstructured":"Zihni, C., Mills, C., Matter, K. & Balda, M. S. Tight junctions: from simple barriers to multifunctional molecular gates. Nat. Rev. Mol. Cell Biol. 17, 564\u2013580 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1028_CR58","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/jth.14371","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba, T. & Levy, J. H. Derangement of the endothelial glycocalyx in sepsis. J. Thromb. Haemost. 17, 283\u2013294 (2019).","journal-title":"J. Thromb. Haemost."},{"key":"1028_CR59","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.4049\/jimmunol.176.11.6991","volume":"176","author":"MP Kuligowski","year":"2006","unstructured":"Kuligowski, M. P., Kitching, A. R. & Hickey, M. J. Leukocyte recruitment to the inflamed glomerulus: a critical role for platelet-derived P-selectin in the absence of rolling. J. Immunol. 176, 6991\u20136999 (2006).","journal-title":"J. Immunol."},{"key":"1028_CR60","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","volume":"96","author":"S Peerapornratana","year":"2019","unstructured":"Peerapornratana, S., Manrique-Caballero, C. L., Gomez, H. & Kellum, J. A. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 96, 1083\u20131099 (2019).","journal-title":"Kidney Int."},{"key":"1028_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00483","volume":"11","author":"H Crijns","year":"2020","unstructured":"Crijns, H., Vanheule, V. & Proost, P. Targeting chemokine-glycosaminoglycan interactions to inhibit inflammation. Front. Immunol. 11, 483 (2020).","journal-title":"Front. Immunol."},{"key":"1028_CR62","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/ni1233","volume":"6","author":"L Wang","year":"2005","unstructured":"Wang, L., Fuster, M., Sriramarao, P. & Esko, J. D. Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat. Immunol. 6, 902\u2013910 (2005).","journal-title":"Nat. Immunol."},{"key":"1028_CR63","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.atherosclerosis.2008.03.024","volume":"202","author":"M Nieuwdorp","year":"2009","unstructured":"Nieuwdorp, M. et al. Tumor necrosis factor-\u03b1 inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 202, 296\u2013303 (2009).","journal-title":"Atherosclerosis"},{"key":"1028_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01037","volume":"10","author":"Y Ma","year":"2019","unstructured":"Ma, Y. et al. Role of neutrophil extracellular traps and vesicles in regulating vascular endothelial permeability. Front. Immunol. 10, 1037 (2019).","journal-title":"Front. Immunol."},{"key":"1028_CR65","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nm.2843","volume":"18","author":"EP Schmidt","year":"2012","unstructured":"Schmidt, E. P. et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat. Med. 18, 1217\u20131223 (2012).","journal-title":"Nat. Med."},{"key":"1028_CR66","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/ki.2011.347","volume":"81","author":"JH Holthoff","year":"2012","unstructured":"Holthoff, J. H., Wang, Z., Seely, K. A., Gokden, N. & Mayeux, P. R. Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury. Kidney Int. 81, 370\u2013378 (2012).","journal-title":"Kidney Int."},{"key":"1028_CR67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jcrc.2017.07.049","volume":"43","author":"M Ikeda","year":"2018","unstructured":"Ikeda, M. et al. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis. J. Crit. Care 43, 48\u201353 (2018).","journal-title":"J. Crit. Care"},{"key":"1028_CR68","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrneph.2013.197","volume":"9","author":"S Satchell","year":"2013","unstructured":"Satchell, S. The role of the glomerular endothelium in albumin handling. Nat. Rev. Nephrol. 9, 717\u2013725 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"1028_CR69","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1046\/j.1523-1755.2001.059002693.x","volume":"59","author":"AJ Branten","year":"2001","unstructured":"Branten, A. J., van den Born, J., Jansen, J. L., Assmann, K. J. & Wetzels, J. F. Familial nephropathy differing from minimal change nephropathy and focal glomerulosclerosis. Kidney Int. 59, 693\u2013701 (2001).","journal-title":"Kidney Int."},{"key":"1028_CR70","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1152\/physrev.1999.79.3.703","volume":"79","author":"CC Michel","year":"1999","unstructured":"Michel, C. C. & Curry, F. E. Microvascular permeability. Physiol. Rev. 79, 703\u2013761 (1999).","journal-title":"Physiol. Rev."},{"key":"1028_CR71","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1681\/ASN.2007010119","volume":"18","author":"A Singh","year":"2007","unstructured":"Singh, A. et al. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J. Am. Soc. Nephrol. 18, 2885\u20132893 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1028_CR72","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2337\/db11-1024","volume":"61","author":"N Gil","year":"2012","unstructured":"Gil, N. et al. Heparanase is essential for the development of diabetic nephropathy in mice. Diabetes 61, 208\u2013216 (2012).","journal-title":"Diabetes"},{"key":"1028_CR73","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00438-022-01854-w","volume":"297","author":"R Khalil","year":"2022","unstructured":"Khalil, R. et al. Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier. Mol. Genet. Genomics 297, 397\u2013405 (2022).","journal-title":"Mol. Genet. Genomics"},{"key":"1028_CR74","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1681\/ASN.2007080842","volume":"19","author":"IS Roberts","year":"2008","unstructured":"Roberts, I. S. & Gleadle, J. M. Familial nephropathy and multiple exostoses with exostosin-1 (EXT1) gene mutation. J. Am. Soc. Nephrol. 19, 450\u2013453 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1028_CR75","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.ajpath.2013.01.049","volume":"182","author":"MJ Dane","year":"2013","unstructured":"Dane, M. J. et al. Glomerular endothelial surface layer acts as a barrier against albumin filtration. Am. J. Pathol. 182, 1532\u20131540 (2013).","journal-title":"Am. J. Pathol."},{"key":"1028_CR76","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1681\/ASN.2019020192","volume":"30","author":"BM van den Berg","year":"2019","unstructured":"van den Berg, B. M. et al. Glomerular function and structural integrity depend on hyaluronan synthesis by glomerular endothelium. J. Am. Soc. Nephrol. 30, 1886\u20131897 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1028_CR77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/CIRCRESAHA.124.325218","volume":"136","author":"Z Hu","year":"2025","unstructured":"Hu, Z. et al. Loss of the endothelial glycocalyx component EMCN leads to glomerular impairment. Circ. Res. 136, 59\u201374 (2025).","journal-title":"Circ. Res."},{"key":"1028_CR78","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2337\/db23-0455","volume":"73","author":"S Fawaz","year":"2024","unstructured":"Fawaz, S. et al. Adiponectin reduces glomerular endothelial glycocalyx disruption and restores glomerular barrier function in a mouse model of type 2 diabetes. Diabetes 73, 964\u2013976 (2024).","journal-title":"Diabetes"},{"key":"1028_CR79","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1042\/cs0970303","volume":"97","author":"C Whittle","year":"1999","unstructured":"Whittle, C., Gillespie, K., Harrison, R., Mathieson, P. W. & Harper, S. J. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Clin. Sci. 97, 303\u2013312 (1999).","journal-title":"Clin. Sci."},{"key":"1028_CR80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1620\/tjem.195.43","volume":"195","author":"Y Kitamoto","year":"2001","unstructured":"Kitamoto, Y., Takeya, M., Tokunaga, H. & Tomita, K. Glomerular endothelial cells are maintained by vascular endothelial growth factor in the adult kidney. Tohoku J. Exp. Med. 195, 43\u201354 (2001).","journal-title":"Tohoku J. Exp. Med."},{"key":"1028_CR81","doi-asserted-by":"publisher","first-page":"C1053","DOI":"10.1152\/ajpcell.00292.2001","volume":"282","author":"J Chen","year":"2002","unstructured":"Chen, J. et al. VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells. Am. J. Physiol. Cell Physiol. 282, C1053\u2013C1063 (2002).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1028_CR82","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/sj.ki.5000277","volume":"69","author":"SC Satchell","year":"2006","unstructured":"Satchell, S. C. et al. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int. 69, 1633\u20131640 (2006).","journal-title":"Kidney Int."},{"key":"1028_CR83","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ki.2010.64","volume":"77","author":"D Veron","year":"2010","unstructured":"Veron, D. et al. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int. 77, 989\u2013999 (2010).","journal-title":"Kidney Int."},{"key":"1028_CR84","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ajpath.2013.04.019","volume":"183","author":"RR Foster","year":"2013","unstructured":"Foster, R. R. et al. Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro. Am. J. Pathol. 183, 604\u2013616 (2013).","journal-title":"Am. J. Pathol."},{"key":"1028_CR85","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1681\/ASN.2014040350","volume":"26","author":"S Oltean","year":"2015","unstructured":"Oltean, S. et al. Vascular endothelial growth factor-A165b is protective and restores endothelial glycocalyx in diabetic nephropathy. J. Am. Soc. Nephrol. 26, 1889\u20131904 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1028_CR86","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/cvr\/cvp093","volume":"83","author":"AH Salmon","year":"2009","unstructured":"Salmon, A. H. et al. Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx. Cardiovasc. Res. 83, 24\u201333 (2009).","journal-title":"Cardiovasc. Res."},{"key":"1028_CR87","first-page":"163","volume":"56","author":"S Desideri","year":"2019","unstructured":"Desideri, S. et al. Endothelial glycocalyx restoration by growth factors in diabetic nephropathy. Biorheology 56, 163\u2013179 (2019).","journal-title":"Biorheology"},{"key":"1028_CR88","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1007\/s00125-010-1810-0","volume":"53","author":"A Kuwabara","year":"2010","unstructured":"Kuwabara, A., Satoh, M., Tomita, N., Sasaki, T. & Kashihara, N. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 53, 2056\u20132065 (2010).","journal-title":"Diabetologia"},{"key":"1028_CR89","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/1475-2840-12-175","volume":"12","author":"BJ Eskens","year":"2013","unstructured":"Eskens, B. J., Zuurbier, C. J., van Haare, J., Vink, H. & van Teeffelen, J. W. Effects of two weeks of metformin treatment on whole-body glycocalyx barrier properties in db\/db mice. Cardiovasc. Diabetol. 12, 175 (2013).","journal-title":"Cardiovasc. Diabetol."},{"key":"1028_CR90","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.2337\/db15-1413","volume":"65","author":"MG Boels","year":"2016","unstructured":"Boels, M. G. et al. Atrasentan reduces albuminuria by restoring the glomerular endothelial glycocalyx barrier in diabetic nephropathy. Diabetes 65, 2429\u20132439 (2016).","journal-title":"Diabetes"},{"key":"1028_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170065","volume":"12","author":"MG Boels","year":"2017","unstructured":"Boels, M. G. et al. Direct observation of enhanced nitric oxide in a murine model of diabetic nephropathy. PLoS ONE 12, e0170065 (2017).","journal-title":"PLoS ONE"},{"key":"1028_CR92","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.ajpath.2017.07.020","volume":"187","author":"MGS Boels","year":"2017","unstructured":"Boels, M. G. S. et al. Systemic monocyte chemotactic protein-1 inhibition modifies renal macrophages and restores glomerular endothelial glycocalyx and barrier function in diabetic nephropathy. Am. J. Pathol. 187, 2430\u20132440 (2017).","journal-title":"Am. J. Pathol."},{"key":"1028_CR93","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.2337\/db14-0001","volume":"63","author":"R Goldberg","year":"2014","unstructured":"Goldberg, R. et al. Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy. Diabetes 63, 4302\u20134313 (2014).","journal-title":"Diabetes"},{"key":"1028_CR94","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.kint.2016.06.035","volume":"90","author":"M Garsen","year":"2016","unstructured":"Garsen, M. et al. Cathepsin L is crucial for the development of early experimental diabetic nephropathy. Kidney Int. 90, 1012\u20131022 (2016).","journal-title":"Kidney Int."},{"key":"1028_CR95","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.ki.5002337","volume":"72","author":"MJVD Hoven","year":"2007","unstructured":"Hoven, M. J. V. D. et al. Heparanase in glomerular diseases. Kidney Int. 72, 543\u2013548 (2007).","journal-title":"Kidney Int."},{"key":"1028_CR96","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrneph.2017.6","volume":"13","author":"TJ Rabelink","year":"2017","unstructured":"Rabelink, T. J. et al. Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease. Nat. Rev. Nephrol. 13, 201\u2013212 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"1028_CR97","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1681\/ASN.2015091070","volume":"27","author":"M Garsen","year":"2016","unstructured":"Garsen, M. et al. Endothelin-1 induces proteinuria by heparanase-mediated disruption of the glomerular glycocalyx. J. Am. Soc. Nephrol. 27, 3545\u20133551 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1028_CR98","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1007\/s00125-010-1910-x","volume":"53","author":"LN Broekhuizen","year":"2010","unstructured":"Broekhuizen, L. N. et al. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia 53, 2646\u20132655 (2010).","journal-title":"Diabetologia"},{"key":"1028_CR99","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2337\/diabetes.55.04.06.db05-1619","volume":"55","author":"M Nieuwdorp","year":"2006","unstructured":"Nieuwdorp, M. et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 55, 1127\u20131132 (2006).","journal-title":"Diabetes"},{"key":"1028_CR100","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1007\/s00125-006-0330-4","volume":"49","author":"K Svennevig","year":"2006","unstructured":"Svennevig, K., Kolset, S. O. & Bangstad, H. J. Increased syndecan-1 in serum is related to early nephropathy in type 1 diabetes mellitus patients. Diabetologia 49, 2214\u20132216 (2006).","journal-title":"Diabetologia"},{"key":"1028_CR101","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/ndt\/gfl598","volume":"22","author":"S Lee","year":"2007","unstructured":"Lee, S. et al. Renoprotective effect of COMP-angiopoietin-1 in db\/db mice with type 2 diabetes. Nephrol. Dial. Transpl. 22, 396\u2013408 (2007).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1028_CR102","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000882","volume":"8","author":"M Tian","year":"2020","unstructured":"Tian, M. et al. Systemic AAV10.COMP-Ang1 rescues renal glomeruli and pancreatic islets in type 2 diabetic mice. BMJ Open Diabetes Res. Care 8, e000882 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"1028_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2021.106919","volume":"141","author":"RG Wallace","year":"2021","unstructured":"Wallace, R. G. et al. COMP-Ang1: therapeutic potential of an engineered angiopoietin-1 variant. Vasc. Pharmacol. 141, 106919 (2021).","journal-title":"Vasc. Pharmacol."},{"key":"1028_CR104","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1681\/ASN.2012121218","volume":"25","author":"C Dessapt-Baradez","year":"2014","unstructured":"Dessapt-Baradez, C. et al. Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease. J. Am. Soc. Nephrol. 25, 33\u201342 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1028_CR105","first-page":"1645","volume":"118","author":"K Sharma","year":"2008","unstructured":"Sharma, K. et al. Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 118, 1645\u20131656 (2008).","journal-title":"J. Clin. Invest."},{"key":"1028_CR106","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","volume":"20","author":"K Hotta","year":"2000","unstructured":"Hotta, K. et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20, 1595\u20131599 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1028_CR107","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ekir.2021.11.037","volume":"7","author":"C Bauer","year":"2022","unstructured":"Bauer, C. et al. Minimal change disease is associated with endothelial glycocalyx degradation and endothelial activation. Kidney Int. Rep. 7, 797\u2013809 (2022).","journal-title":"Kidney Int. Rep."},{"key":"1028_CR108","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1523-1755.2005.00062.x","volume":"67","author":"RC Holt","year":"2005","unstructured":"Holt, R. C. et al. Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome. Kidney Int. 67, 122\u2013129 (2005).","journal-title":"Kidney Int."},{"key":"1028_CR109","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211010256","volume":"27","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. The association of syndecan-1, hypercoagulable state and thrombosis and in patients with nephrotic syndrome. Clin. Appl. Thromb. Hemost. 27, 10760296211010256 (2021).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"1028_CR110","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.177775","volume":"9","author":"G Gyarmati","year":"2024","unstructured":"Gyarmati, G. et al. Sparsentan improves glomerular hemodynamics, cell functions, and tissue repair in a mouse model of FSGS. JCI Insight 9, e177775 (2024).","journal-title":"JCI Insight"},{"key":"1028_CR111","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1093\/ndt\/gfae021","volume":"39","author":"H Nagasawa","year":"2024","unstructured":"Nagasawa, H. et al. Sparsentan is superior to losartan in the gddY mouse model of IgA nephropathy. Nephrol. Dial. Transpl. 39, 1494\u20131503 (2024).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1028_CR112","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/BF00157811","volume":"25","author":"M Salamat","year":"1993","unstructured":"Salamat, M., Gotz, W., Werner, J. & Herken, R. Ultrastructural localization of lectin-binding sites in different basement membranes. Histochem. J. 25, 464\u2013468 (1993).","journal-title":"Histochem. J."},{"key":"1028_CR113","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010647","volume":"8","author":"TL Weissgerber","year":"2019","unstructured":"Weissgerber, T. L. et al. Early onset preeclampsia is associated with glycocalyx degradation and reduced microvascular perfusion. J. Am. Heart Assoc. 8, e010647 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"1028_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preghy.2023.02.001","volume":"32","author":"K Watanabe","year":"2023","unstructured":"Watanabe, K. et al. Increased urinary albumin leakage is related to injuries of glomerular glycocalyx and podocytes, and associated with tubular dysfunction in preeclampsia. Pregnancy Hypertens. 32, 1\u20136 (2023).","journal-title":"Pregnancy Hypertens."},{"key":"1028_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.791309","volume":"8","author":"K Kusuzawa","year":"2021","unstructured":"Kusuzawa, K. et al. Measuring the concentration of serum syndecan-1 to assess vascular endothelial glycocalyx injury during hemodialysis. Front. Med. 8, 791309 (2021).","journal-title":"Front. Med."},{"key":"1028_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061803","volume":"9","author":"HB Kim","year":"2020","unstructured":"Kim, H. B. et al. High preoperative serum syndecan-1, a marker of endothelial glycocalyx degradation, and severe acute kidney injury after valvular heart surgery. J. Clin. Med. 9, 1803 (2020).","journal-title":"J. Clin. Med."},{"key":"1028_CR117","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1159\/000517317","volume":"46","author":"H Liew","year":"2021","unstructured":"Liew, H., Roberts, M. A. & McMahon, L. P. Markers of the endothelial glycocalyx are improved following kidney transplantation. Kidney Blood Press. Res. 46, 581\u2013587 (2021).","journal-title":"Kidney Blood Press. Res."},{"key":"1028_CR118","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.biocel.2018.03.018","volume":"99","author":"G Porras","year":"2018","unstructured":"Porras, G., Ayuso, M. S. & Gonzalez-Manchon, C. Leukocyte-endothelial cell interaction is enhanced in podocalyxin-deficient mice. Int. J. Biochem. Cell Biol. 99, 72\u201379 (2018).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1028_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02219-4","volume":"22","author":"H Liew","year":"2021","unstructured":"Liew, H., Roberts, M. A., Pope, A. & McMahon, L. P. Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction. BMC Nephrol. 22, 21 (2021).","journal-title":"BMC Nephrol."},{"key":"1028_CR120","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ajpath.2022.11.003","volume":"193","author":"K Ermert","year":"2023","unstructured":"Ermert, K., Buhl, E. M., Klinkhammer, B. M., Floege, J. & Boor, P. Reduction of endothelial glycocalyx on peritubular capillaries in chronic kidney disease. Am. J. Pathol. 193, 138\u2013147 (2023).","journal-title":"Am. J. Pathol."},{"key":"1028_CR121","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1681\/ASN.2012010017","volume":"23","author":"AH Salmon","year":"2012","unstructured":"Salmon, A. H. et al. Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction. J. Am. Soc. Nephrol. 23, 1339\u20131350 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1028_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810659","volume":"23","author":"B Fels","year":"2022","unstructured":"Fels, B. et al. Effects of chronic kidney disease on nanomechanics of the endothelial glycocalyx are mediated by the mineralocorticoid receptor. Int. J. Mol. Sci. 23, 10659 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1028_CR123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055852","volume":"8","author":"A Singh","year":"2013","unstructured":"Singh, A. et al. Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx. PLoS ONE 8, e55852 (2013).","journal-title":"PLoS ONE"},{"key":"1028_CR124","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ajpath.2015.12.008","volume":"186","author":"M Garsen","year":"2016","unstructured":"Garsen, M. et al. Heparanase is essential for the development of acute experimental glomerulonephritis. Am. J. Pathol. 186, 805\u2013815 (2016).","journal-title":"Am. J. Pathol."},{"key":"1028_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1841-8","volume":"21","author":"H Okada","year":"2017","unstructured":"Okada, H. et al. Three-dimensional ultrastructure of capillary endothelial glycocalyx under normal and experimental endotoxemic conditions. Crit. Care 21, 261 (2017).","journal-title":"Crit. Care"},{"key":"1028_CR126","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ki.2013.286","volume":"85","author":"C Xu","year":"2014","unstructured":"Xu, C. et al. TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis. Kidney Int. 85, 72\u201381 (2014).","journal-title":"Kidney Int."},{"key":"1028_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/cc10559","volume":"15","author":"C Adembri","year":"2011","unstructured":"Adembri, C. et al. Sepsis induces albuminuria and alterations in the glomerular filtration barrier: a morphofunctional study in the rat. Crit. Care 15, R277 (2011).","journal-title":"Crit. Care"},{"key":"1028_CR128","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nm.3024","volume":"19","author":"S Devi","year":"2013","unstructured":"Devi, S. et al. Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus. Nat. Med. 19, 107\u2013112 (2013).","journal-title":"Nat. Med."},{"key":"1028_CR129","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/sj.ki.5002573","volume":"73","author":"AL Rops","year":"2008","unstructured":"Rops, A. L. et al. Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking. Kidney Int. 73, 52\u201362 (2008).","journal-title":"Kidney Int."},{"key":"1028_CR130","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.ki.5000014","volume":"69","author":"FY Chow","year":"2006","unstructured":"Chow, F. Y. et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int. 69, 73\u201380 (2006).","journal-title":"Kidney Int."},{"key":"1028_CR131","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/MNH.0000000000000186","volume":"25","author":"H Haller","year":"2016","unstructured":"Haller, H., Bertram, A., Nadrowitz, F. & Menne, J. Monocyte chemoattractant protein-1 and the kidney. Curr. Opin. Nephrol. Hypertens. 25, 42\u201349 (2016).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"1028_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1223972","volume":"10","author":"B Buijsers","year":"2023","unstructured":"Buijsers, B. et al. Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis. Front. Mol. Biosci. 10, 1223972 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"1028_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1177560","volume":"10","author":"ML Maciej-Hulme","year":"2023","unstructured":"Maciej-Hulme, M. L. et al. Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis. Front. Mol. Biosci. 10, 1177560 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"1028_CR134","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","volume":"75","author":"AS Levey","year":"2020","unstructured":"Levey, A. S. et al. Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency. Am. J. Kidney Dis. 75, 84\u2013104 (2020).","journal-title":"Am. J. Kidney Dis."},{"key":"1028_CR135","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S2213-8587(18)30314-0","volume":"7","author":"HJL Heerspink","year":"2019","unstructured":"Heerspink, H. J. L. et al. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. Lancet Diabetes Endocrinol. 7, 128\u2013139 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1028_CR136","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1111\/j.1523-1755.2005.00756.x","volume":"68","author":"KJ Schjoedt","year":"2005","unstructured":"Schjoedt, K. J. et al. Beneficial impact of spironolactone in diabetic nephropathy. Kidney Int. 68, 2829\u20132836 (2005).","journal-title":"Kidney Int."},{"key":"1028_CR137","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/jama.2015.10081","volume":"314","author":"GL Bakris","year":"2015","unstructured":"Bakris, G. L. et al. Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial. JAMA 314, 884\u2013894 (2015).","journal-title":"JAMA"},{"key":"1028_CR138","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.ekir.2021.05.027","volume":"6","author":"PI Georgianos","year":"2021","unstructured":"Georgianos, P. I. & Agarwal, R. Mineralocorticoid receptor antagonism in chronic kidney disease. Kidney Int. Rep. 6, 2281\u20132291 (2021).","journal-title":"Kidney Int. Rep."},{"key":"1028_CR139","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/S0140-6736(19)30772-X","volume":"393","author":"HJL Heerspink","year":"2019","unstructured":"Heerspink, H. J. L. et al. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet 393, 1937\u20131947 (2019).","journal-title":"Lancet"},{"key":"1028_CR140","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.kint.2019.05.007","volume":"96","author":"K Ebefors","year":"2019","unstructured":"Ebefors, K. et al. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells. Kidney Int. 96, 957\u2013970 (2019).","journal-title":"Kidney Int."},{"key":"1028_CR141","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1172\/JCI71195","volume":"124","author":"I Daehn","year":"2014","unstructured":"Daehn, I. et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J. Clin. Invest. 124, 1608\u20131621 (2014).","journal-title":"J. Clin. Invest."},{"key":"1028_CR142","doi-asserted-by":"publisher","first-page":"380S","DOI":"10.1093\/ajh\/1.4.380S","volume":"1","author":"S Anderson","year":"1988","unstructured":"Anderson, S. & Brenner, B. M. Therapeutic benefit of converting-enzyme inhibition in progressive renal disease. Am. J. Hypertens. 1, 380S\u2013383S (1988).","journal-title":"Am. J. Hypertens."},{"key":"1028_CR143","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1056\/NEJMoa053107","volume":"354","author":"FF Hou","year":"2006","unstructured":"Hou, F. F. et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N. Engl. J. Med. 354, 131\u2013140 (2006).","journal-title":"N. Engl. J. Med."},{"key":"1028_CR144","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1056\/NEJMoa011489","volume":"345","author":"HH Parving","year":"2001","unstructured":"Parving, H. H. et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 345, 870\u2013878 (2001).","journal-title":"N. Engl. J. Med."},{"key":"1028_CR145","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1172\/JCI112521","volume":"77","author":"R Zatz","year":"1986","unstructured":"Zatz, R. et al. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J. Clin. Invest. 77, 1925\u20131930 (1986).","journal-title":"J. Clin. Invest."},{"key":"1028_CR146","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1681\/ASN.2019020109","volume":"31","author":"J Binz-Lotter","year":"2020","unstructured":"Binz-Lotter, J. et al. Injured podocytes are sensitized to angiotensin II-induced calcium signaling. J. Am. Soc. Nephrol. 31, 532\u2013542 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1028_CR147","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11892-006-0060-5","volume":"6","author":"C Savoia","year":"2006","unstructured":"Savoia, C. & Schiffrin, E. L. Inhibition of the renin angiotensin system: implications for the endothelium. Curr. Diab Rep. 6, 274\u2013278 (2006).","journal-title":"Curr. Diab Rep."},{"key":"1028_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216543","volume":"24","author":"M Locatelli","year":"2023","unstructured":"Locatelli, M. et al. Endothelial glycocalyx of peritubular capillaries in experimental diabetic nephropathy: a target of ACE inhibitor-induced kidney microvascular protection. Int. J. Mol. Sci. 24, 16543 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1028_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/biom13061004","volume":"13","author":"M Crompton","year":"2023","unstructured":"Crompton, M., Skinner, L. J., Satchell, S. C. & Butler, M. J. Aldosterone: essential for life but damaging to the vascular endothelium. Biomolecules 13, 1004 (2023).","journal-title":"Biomolecules"},{"key":"1028_CR150","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41581-022-00535-6","volume":"18","author":"AB van der Aart-van der Beek","year":"2022","unstructured":"van der Aart-van der Beek, A. B., de Boer, R. A. & Heerspink, H. J. L. Kidney and heart failure outcomes associated with SGLT2 inhibitor use. Nat. Rev. Nephrol. 18, 294\u2013306 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1028_CR151","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/dom.15346","volume":"26","author":"T Lieverse","year":"2024","unstructured":"Lieverse, T. et al. Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: a post-hoc analysis of the ROTATE-3 study. Diabetes Obes. Metab. 26, 576\u2013582 (2024).","journal-title":"Diabetes Obes. Metab."},{"key":"1028_CR152","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","volume":"391","author":"V Perkovic","year":"2024","unstructured":"Perkovic, V. et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N. Engl. J. Med. 391, 109\u2013121 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1028_CR153","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/dc22-1889","volume":"46","author":"HJL Heerspink","year":"2023","unstructured":"Heerspink, H. J. L. et al. Effects of semaglutide on albuminuria and kidney function in people with overweight or obesity with or without type 2 diabetes: exploratory analysis from the STEP 1, 2, and 3 trials. Diabetes Care 46, 801\u2013810 (2023).","journal-title":"Diabetes Care"},{"key":"1028_CR154","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae122","volume":"8","author":"E Korakas","year":"2024","unstructured":"Korakas, E. et al. Semaglutide concurrently improves vascular and liver indices in patients with type 2 diabetes and fatty liver disease. J. Endocr. Soc. 8, bvae122 (2024).","journal-title":"J. Endocr. Soc."},{"key":"1028_CR155","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(23)02302-4","volume":"402","author":"BH Rovin","year":"2023","unstructured":"Rovin, B. H. et al. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial. Lancet 402, 2077\u20132090 (2023).","journal-title":"Lancet"},{"key":"1028_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096477","volume":"9","author":"DH Lee","year":"2014","unstructured":"Lee, D. H. et al. Deeper penetration of erythrocytes into the endothelial glycocalyx is associated with impaired microvascular perfusion. PLoS ONE 9, e96477 (2014).","journal-title":"PLoS ONE"},{"key":"1028_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22947-x","volume":"12","author":"ME Bol","year":"2022","unstructured":"Bol, M. E., Broddin, B. E. K., Delhaas, T., Sels, J. E. M. & van de Poll, M. C. G. Variability of microcirculatory measurements in healthy volunteers. Sci. Rep. 12, 19887 (2022).","journal-title":"Sci. Rep."},{"key":"1028_CR158","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/SHK.0000000000001470","volume":"54","author":"ME Bol","year":"2020","unstructured":"Bol, M. E. et al. Variability of microcirculatory measurements in critically Ill patients. Shock 54, 9\u201314 (2020).","journal-title":"Shock"},{"key":"1028_CR159","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00652-2021","volume":"8","author":"L Yuan","year":"2022","unstructured":"Yuan, L. et al. Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx and protects against dysfunction induced by serum of COVID-19 patients in the intensive care unit. ERJ Open Res. 8, 0065-2021 (2022).","journal-title":"ERJ Open Res."},{"key":"1028_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41387-024-00275-5","volume":"14","author":"AIM van der Velden","year":"2024","unstructured":"van der Velden, A. I. M. et al. Role of dietary interventions on microvascular health in South-Asian Surinamese people with type 2 diabetes in the Netherlands: a randomized controlled trial. Nutr. Diabetes 14, 17 (2024).","journal-title":"Nutr. Diabetes"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01028-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01028-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01028-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:02:19Z","timestamp":1771592539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01028-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":160,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1038\/s41581-025-01028-y","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"22 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}